HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $131,266 | -95.3% | 23,910 | -94.1% | 0.01% | -94.5% |
| Q3 2021 | $2,816,000 | -29.6% | 403,291 | -16.0% | 0.22% | -31.8% |
| Q2 2021 | $4,000,000 | +81.7% | 480,140 | +19.1% | 0.32% | +72.8% |
| Q1 2021 | $2,202,000 | +27.3% | 403,291 | 0.0% | 0.18% | +12.2% |
| Q4 2020 | $1,730,000 | +42.0% | 403,291 | -0.3% | 0.16% | +37.8% |
| Q3 2020 | $1,218,000 | -4.8% | 404,591 | -2.0% | 0.12% | +1.7% |
| Q2 2020 | $1,280,000 | +7429.4% | 412,891 | +12802.8% | 0.12% | +5750.0% |
| Q3 2018 | $17,000 | -94.1% | 3,200 | -93.5% | 0.00% | -97.3% |
| Q1 2015 | $287,000 | +2.5% | 49,300 | 0.0% | 0.07% | +2.8% |
| Q4 2014 | $280,000 | – | 49,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |